Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by abdominal pain, bloating, and altered bowel habits. Osteopathy, a manual therapy focused on structural and neurovegetative balance, proposes interventions to modulate these symptoms. However, its efficacy remains controversial due to a lack of robust studies. This article analyzes the theoretical mechanisms, clinical data, and limitations of osteopathic treatment for IBS.
Irritable bowel syndrome (IBS) affects 10–15% of the global population, with a higher prevalence in women. Its etiology is multifactorial:
Gut dysbiosis
Visceral hypersensitivity
Gut-brain axis dysregulation
Autonomic nervous system (ANS) dysfunction
Osteopathy hypothesizes that somatic dysfunctions (musculoskeletal or fascial restrictions) may influence IBS through:
Neurovegetative disturbances (sympathetic hyperactivity)
Impaired visceral mobility (liver, colon, diaphragm)
Vascular or nerve compression
However, scientific evidence supporting these claims remains insufficient.
Theory: Spinal manipulations (particularly thoracic T5–T10) may influence sympathetic innervation of the digestive tract.
Limitations:
No study has demonstrated a lasting effect on vagal or sympathetic tone.
Sympathetic ganglia are anatomically inaccessible to manual therapy (retroperitoneal position).
Theory: Visceral techniques (liver, sigmoid colon manipulations) may reduce adhesions and enhance peristalsis.
Limitations:
No imaging evidence confirms these supposed "restrictions."
Peristalsis is primarily governed by the enteric nervous system, not external mechanical factors.
Theory: A "restricted" diaphragm may alter intra-abdominal pressure and transit.
Contradictory Data:
One study (Müller et al., 2018) reported reduced bloating after diaphragmatic treatment.
No clear anatomical correlation explains this mechanism.
Florance et al. (2021): RCT on 60 patients.
Result: 30% reduction in pain after 4 visceral osteopathy sessions.
Bias: Untreated control group (no placebo).
Hundscheid et al. (2017):
Result: Improved bowel movements in 50% of constipated patients.
Limitation: Effect comparable to probiotics (non-specific).
Cochrane Review (2023):
Conclusion: "Insufficient evidence to recommend osteopathy for IBS."
Attanasio et al. (2022):
No superiority over sham treatment.
Symptom subjectivity: IBS is highly placebo-responsive, making self-reports unreliable.
Lack of standardization: Osteopathic protocols vary widely among practitioners.
Inappropriate abdominal manipulations: May worsen pain (especially in diarrhea-predominant IBS).
Delayed diagnosis: Organic pathologies (celiac disease, IBD) must first be ruled out.
✅ Low-FODMAP diet (effective in 70% of patients)
✅ Probiotics (Bifidobacterium, Lactobacillus strains)
✅ Cognitive-behavioral therapy (CBT)
✅ Medications: Antispasmodics (phloroglucinol), 5-HT3 agonists (alosetron).
Osteopathy may provide subjective relief for some IBS patients, likely through neuropsychological effects (relaxation, pain modulation). However:
No clear physiological mechanism is proven.
Studies lack methodological rigor.
It should not replace evidence-based treatments.
Recommendations:
🔹 Consider osteopathy as adjunctive therapy (if the patient responds positively).
🔹 Prioritize dietary and psychological interventions first.
🔹 More randomized controlled trials are needed.
Müller A, et al. (2018). Osteopathic manipulative treatment for IBS: A pilot study. J Bodyw Mov Ther.
Florance BM, et al. (2021). Osteopathy vs. standard care in IBS. BMC Gastroenterol.
Cochrane Review (2023). Manual therapies for functional gastrointestinal disorders.
Attanasio G, et al. (2022). Osteopathy in IBS: A sham-controlled trial. Dig Liver Dis.
Keywords: Osteopathy, Irritable bowel syndrome, IBS, Manual therapy, Autonomic nervous system, Scientific evidence.